Filling the need for trusted information on national health issues…

Experimental Ebola Drug Shows Promise In Treating Early Infection, Study Shows

Agence France-Presse: Limited promise in early results from Ebola drug trial
“Early results from an Ebola trial using the experimental drug Avigan (favipiravir) showed it was somewhat effective at saving lives if given early in the illness, but not later…” (2/23).

Reuters: Ebola drug in Guinea helps some, stirs debate on broader use
“…Alliance for International Medical Action (ALIMA), which ran the trials of favipiravir in Guinea, said mortality rates fell from 30 to 15 percent in patients with a low to moderate Ebola count but was not effective on those with a high level of the virus…” (Farge, 2/23).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.